血管アクセスデバイス市場は、2024年の59億9000万ドルから、予測期間中に7.1%のCAGRで成長し、2030年までに90億5000万ドルに達すると予想されます。血管アクセスデバイス市場における著名なプレーヤーには、Becton, Dickinson and Company(米国)、Teleflex Incorporated(米国)、ICU Medical, Inc.(米国)、B. Braun SE(ドイツ)、AngioDynamics, Inc.(米国)、Medtronic(アイルランド)、Merit Medical Systems Inc.(米国)、テルモコーポレーション(日本)、ニプロメディカルコーポレーション(日本)、Vygon(フランス)、AMECATH(エジプト)、Medical Components, Inc.(米国)、Health Line International Corporation(米国)、Cook Medical(米国)、 Access Vascular, Inc.(米国)などがあります。
目次
Table of Contents
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Objectives of secondary research
2.1.1.2 Key secondary sources
2.1.1.3 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Key objectives of primary research
2.1.2.3 Key data from primary sources
2.1.2.4 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
2.2.2 TOP-DOWN APPROACH
2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
2.2.4 DEMAND-SIDE ANALYSIS
2.3 GROWTH FORECAST
2.4 DATA TRIANGULATION
2.5 MARKET RANKING ANALYSIS
2.6 STUDY ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VASCULAR ACCESS DEVICES MARKET OVERVIEW
4.2 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER
AND COUNTRY, 2023
4.3 GEOGRAPHIC SNAPSHOT OF VASCULAR ACCESS DEVICES MARKET, 2023
4.4 REGIONAL MIX: VASCULAR ACCESS DEVICES MARKET, 2024-2030 (USD MILLION)
4.5 VASCULAR ACCESS DEVICES MARKET: EMERGING VS. DEVELOPED MARKETS,
2024 VS. 2030 (USD MILLION)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of lifestyle diseases
5.2.1.2 Increasing popularity of chemotherapy procedures
among cancer patients
5.2.1.3 Rising use of vascular access devices among pediatric patients
5.2.2 RESTRAINTS
5.2.2.1 High cost of installation and maintenance of vascular access devices
5.2.2.2 Rising product recalls and failures
5.2.3 OPPORTUNITIES
5.2.3.1 Technological advancements
5.2.3.2 Increasing number of hospitals and expanding patient pool
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled healthcare professionals
5.2.4.2 Risks associated with use of vascular access devices
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 Imaging and navigation technologies
5.3.1.2 Catheter securement and stabilization technologies
5.3.2 COMPLEMENTARY TECHNOLOGIES
5.3.2.1 AI and ML
5.3.3 ADJACENT TECHNOLOGIES
5.3.3.1 Infection control technologies
5.4 INDUSTRY TRENDS
5.4.1 MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES
5.4.2 INNOVATIONS IN CATHETER MATERIALS AND COATINGS
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.6.1 ROLE IN ECOSYSTEM
5.7 SUPPLY CHAIN ANALYSIS
5.8 TRADE ANALYSIS
5.8.1 IMPORT DATA FOR HS CODE 901839
5.8.2 EXPORT DATA FOR HS CODE 901839
5.9 PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 KEY STAKEHOLDERS & BUYING CRITERIA
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.10.2 KEY BUYING CRITERIA
5.11 REGULATORY ANALYSIS
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS
5.11.2 REGULATORY FRAMEWORK
5.11.2.1 North America
5.11.2.1.1 US
5.11.2.1.2 Canada
5.11.2.2 Europe
5.11.2.3 Asia Pacific
5.11.2.4 Latin America
5.11.2.5 Middle East & Africa
5.12 PATENT ANALYSIS
5.12.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.13 PRICING ANALYSIS
5.13.1 INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES,
BY KEY PLAYER, 2021-2023
5.13.2 INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES,
BY REGION, 2021-2023
5.14 KEY CONFERENCES & EVENTS, 2025-2026
5.15 ADJACENT MARKET ANALYSIS
5.15.1 VASCULAR CLOSURE DEVICES MARKET
5.16 UNMET NEEDS/END-USER EXPECTATIONS
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 IMPACT OF AI/GEN AI ON VASCULAR ACCESS DEVICES MARKET
6 VASCULAR ACCESS DEVICES MARKET, BY TYPE
6.1 INTRODUCTION
6.2 CENTRAL VENOUS ACCESS DEVICES
6.2.1 PERIPHERALLY INSERTED CENTRAL CATHETERS
6.2.1.1 Better durability and increased clinical utility for extended treatment plans to drive segment
6.2.2 TUNNELED CATHETERS
6.2.2.1 Lower risk of infection and superior longevity to support
segment growth
6.2.3 NON-TUNNELED CATHETERS
6.2.3.1 Non-tunneled catheters to be used in critical cases with limited peripheral access
6.2.4 IMPLANTABLE PORTS
6.2.4.1 Implantable conventional ports
6.2.4.1.1 Ability to provide reliable venous access with minimal maintenance to spur adoption
6.2.4.2 Implantable power injectable ports
6.2.4.2.1 Ability to accommodate high-flow fluids and increased demand for chemotherapy to propel market growth
6.3 PERIPHERAL VASCULAR ACCESS DEVICES
6.3.1 PERIPHERAL VENOUS ACCESS DEVICES
6.3.1.1 Peripheral intravenous catheters
6.3.1.1.1 Cost-effectiveness, ease of placement, and compatibility with different treatments to augment segment growth
6.3.1.2 Midline catheters
6.3.1.2.1 Ability to provide reliable medium-term intravenous access from one to four weeks to aid segment growth
6.3.1.3 Butterfly/Winged steel needles
6.3.1.3.1 Precision and comfort in short-term venous access procedures to drive segment
6.3.2 PERIPHERAL ARTERIAL ACCESS DEVICES
6.3.2.1 Critical role in continuous hemodynamic monitoring and blood sampling in acute care settings to propel segment growth
6.4 ACCESSORIES
6.4.1 NEED FOR ENHANCED FUNCTIONALITY, PATIENT SAFETY, AND PROCEDURAL EFFICIENCY TO DRIVE MARKET
6.5 INTRAOSSEOUS VASCULAR ACCESS DEVICES
6.5.1 CRITICAL ROLE IN EMERGENCY SITUATIONS TO FUEL UPTAKE IN HIGH-STRESS HEALTHCARE FACILITIES
7 VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION
7.1 INTRODUCTION
7.2 INTRAVENOUS ROUTE OF INSERTION
7.2.1 RISING NEED FOR ADMINISTERING ESSENTIAL TREATMENTS DURING ACUTE CARE TO AID MARKET GROWTH
7.3 SUBCUTANEOUS ROUTE OF INSERTION
7.3.1 REDUCED INFECTION RISK, BETTER PATIENT COMFORT, AND MINIMAL MAINTENANCE TO AUGMENT MARKET GROWTH
7.4 INTRAOSSEOUS ROUTE OF INSERTION
7.4.1 NEED FOR RAPID AND RELIABLE ACCESS IN CRITICAL EMERGENCIES
TO FUEL UPTAKE
8 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 DRUG ADMINISTRATION
8.2.1 CHEMOTHERAPY
8.2.1.1 Increased incidence of cancer and advancements in oncology care to drive segment
8.2.2 OTHER DRUG ADMINISTRATION
8.3 FLUID & NUTRITION ADMINISTRATION
8.3.1 INCREASING NEED FOR INTRAVENOUS THERAPY IN CHRONIC DISEASES TO SPUR MARKET GROWTH
8.4 BLOOD TRANSFUSION
8.4.1 FREQUENT NEED FOR BLOOD TRANSFUSION FOR THALASSEMIA AND LYMPHOMA TO BOOST MARKET GROWTH
8.5 DIAGNOSTICS & TESTING
8.5.1 INCREASING RELIANCE ON ACCURATE DIAGNOSTIC IMAGING, FLUID TESTING, AND PATIENT MONITORING TO AID MARKET GROWTH
9 VASCULAR ACCESS DEVICES MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.2.1 PUBLIC HOSPITALS
9.2.1.1 Increasing demand for affordable healthcare services in emerging economies to drive segment
9.2.2 PRIVATE HOSPITALS
9.2.2.1 Rising demand for advanced healthcare services and high-quality treatment options to drive market
9.3 CLINICS & AMBULATORY CARE CENTERS
9.3.1 INCREASING DEMAND FOR OUTPATIENT PROCEDURES AND COST-EFFECTIVE TREATMENTS TO BOOST SEGMENT GROWTH
9.4 OTHER END USERS
10 VASCULAR ACCESS DEVICES MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to dominate North American vascular access devices market during forecast period
10.2.3 CANADA
10.2.3.1 Rising cancer prevalence and advanced research initiatives to
propel market growth
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Rising obesity rates and growing geriatric population to augment market growth
10.3.3 UK
10.3.3.1 Increased disease burden to fuel uptake for advanced vascular access devices for better treatment procedures
10.3.4 FRANCE
10.3.4.1 Presence of vascular access device manufacturers and technological advancements to fuel market growth
10.3.5 ITALY
10.3.5.1 Strong government healthcare policies to boost market growth
10.3.6 SPAIN
10.3.6.1 Growing geriatric population and rising incidence of chronic diseases to fuel market growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 CHINA
10.4.2.1 Advanced healthcare infrastructure and high geriatric population to support market growth
10.4.3 INDIA
10.4.3.1 Rising governmental health expenditure and increasing incidence of chronic diseases to fuel market growth
10.4.4 JAPAN
10.4.4.1 Increased geriatric population and high prevalence of cancer to drive market
10.4.5 AUSTRALIA
10.4.5.1 Increased demand for hemodialysis and advancements in healthcare infrastructure to propel market growth
10.4.6 SOUTH KOREA
10.4.6.1 Rising burden of chronic diseases and increasing aged population to boost market growth
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Growing cancer burden and rising need for long-term treatment for chronic patients to drive market
10.5.3 MEXICO
10.5.3.1 Increasing focus on dialysis for patients with chronic kidney diseases to drive adoption of advanced vascular access devices
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 Increasing healthcare investments and rising prevalence of chronic diseases to propel market growth
10.6.3 REST OF MIDDLE EAST & AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET
11.3 REVENUE ANALYSIS, 2019-2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Type footprint
11.5.5.4 Route of insertion footprint
11.5.5.5 Application footprint
11.5.5.6 End-user footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
11.6.5.1 Detailed list of key startup/SME players
11.6.5.2 Competitive benchmarking of key emerging players/startups
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES & APPROVALS
11.9.2 DEALS
11.9.3 OTHER DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 BECTON, DICKINSON AND COMPANY
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Deals
12.1.1.4 MnM view
12.1.1.4.1 Key strengths
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 TELEFLEX INCORPORATED
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches
12.1.2.3.2 Other developments
12.1.2.4 MnM view
12.1.2.4.1 Key strengths
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 ICU MEDICAL
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 Recent developments
12.1.3.3.1 Deals
12.1.3.4 MnM view
12.1.3.4.1 Key strengths
12.1.3.4.2 Strategic choices
12.1.3.4.3 Weaknesses & competitive threats
12.1.4 NIPRO
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 MnM view
12.1.4.3.1 Key strengths
12.1.4.3.2 Strategic choices
12.1.4.3.3 Weaknesses & competitive threats
12.1.5 ANGIODYNAMICS, INC.
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 Recent developments
12.1.5.3.1 Product approvals
12.1.5.3.2 Deals
12.1.5.4 MnM view
12.1.5.4.1 Key strengths
12.1.5.4.2 Strategic choices
12.1.5.4.3 Weaknesses & competitive threats
12.1.6 VYGON
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.7 TERUMO CORPORATION
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.8 MEDTRONIC PLC
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.9 COOK
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.10 B. BRAUN SE
12.1.10.1 Business overview
12.1.10.2 Products offered
12.1.10.3 Recent developments
12.1.10.3.1 Product launches & approvals
12.1.10.3.2 Deals
12.1.11 MERIT MEDICAL SYSTEMS, INC.
12.1.11.1 Business overview
12.1.11.2 Products offered
12.1.11.3 Recent developments
12.1.11.3.1 Deals
12.1.12 AMECATH
12.1.12.1 Business overview
12.1.12.2 Products offered
12.1.13 MEDICAL COMPONENTS, INC.
12.1.13.1 Business overview
12.1.13.2 Products offered
12.1.14 HEALTHLINE MEDICAL PRODUCTS
12.1.14.1 Business overview
12.1.14.2 Products offered
12.1.15 ACCESS VASCULAR, INC.
12.1.15.1 Business overview
12.1.15.2 Products offered
12.2 OTHER PLAYERS
12.2.1 ARGON MEDICAL DEVICES
12.2.2 PAKUMEDMEDICAL PRODUCTS GMBH
12.2.3 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
12.2.4 PFM MEDICAL GMBH
12.2.5 MEDI-TECH DEVICES PVT. LTD.
12.2.6 KIMAL
12.2.7 POLYMEDICURE
12.2.8 DELTAMED
12.2.9 NEWTECH MEDICAL DEVICES PVT. LTD.
12.2.10 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
